With around 10,000 diseases known to humankind and over 90% that still have no approved treatments, there’s considerable demand in the specialized life science sector. As Joel Marcus, co-founder and ...
Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback